Sana Biotechnology (NASDAQ: SANA)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-03 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.470 | -0.470 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sana Biotechnology (NASDAQ: SANA) through any online brokerage.
Other companies in Sana Biotechnology’s space includes: Chinook Therapeutics (NASDAQ:KDNY), Syndax Pharmaceuticals (NASDAQ:SNDX), FibroGen (NASDAQ:FGEN), TG Therapeutics (NASDAQ:TGTX) and Alector (NASDAQ:ALEC).
The latest price target for Sana Biotechnology (NASDAQ: SANA) was reported by Morgan Stanley on Tuesday, May 17, 2022. The analyst firm set a price target for 15.00 expecting SANA to rise to within 12 months (a possible 240.91% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Sana Biotechnology (NASDAQ: SANA) is $4.4 last updated May 23, 2022, 8:00 PM UTC.
There are no upcoming dividends for Sana Biotechnology.
Sana Biotechnology’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for Sana Biotechnology.
Sana Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.